Psychiatrist-St. Louis (1099)-Greenbrook

Neuronetics, Inc.; St. Louis (MO); On-site; USD 90,000 - 120,000; Part time

Benefits offered by this job

Flexible part-time schedule (1099)

No nights, weekends, or on-call

Competitive compensation

TMS certification and training

Interventional psychiatry growth

Collaborative team support

Job summary

Greenbrook Mental Wellness Centers is seeking a Board Certified or Board Eligible Psychiatrist to provide onsite oversight of Transcranial Magnetic Stimulation (TMS) treatments and support the Spravato program in St. Louis, MO.

The role offers flexible part-time, 1099 engagement with no nights, weekends, or on-call duties. Qualifications include MD or DO, Missouri medical license (or ability to obtain) and DEA registration.

Qualifications

• MD or DO required.
• Board Certified or Board Eligible ideal.
• Active Missouri medical license (or ability to obtain) and DEA registration.

Responsibilities

• Provide onsite oversight of TMS treatments.
• Support growth of Spravato program in St. Louis, MO.
• Collaborate with clinical and operational teams to deliver high-quality care.

Skills

Interventional psychiatry

Collaborative care

Education

MD or DO

Tools

Missouri medical license

DEA registration

Job description

Greenbrook Mental Wellness Centers, a subsidiary of Neuronetics, Inc., is seeking a Board Certified or Board Eligible Psychiatrist to provide onsite oversight of Transcranial Magnetic Stimulation (TMS) treatments and support the growth of our Spravato® (esketamine) program in St. Louis, MO.
Why Join Us?

• Flexible part-time schedule (1099)
• No nights, weekends, or on-call responsibilities
• Competitive compensation
• TMS certification and training provided
• Opportunity to expand your expertise in interventional psychiatry
• Collaborative clinical and operational support team
• Make a meaningful impact on patients with treatment-resistant depression and other mental health disorders
  

Qualifications

• MD or DO
• Board Certified or Board Eligible
• Active Missouri medical license (or ability to obtain)
• DEA registration (or ability to obtain)
  

About Greenbrook
As a leading provider of FDA-cleared, non-invasive therapies for Major Depressive Disorder (MDD) and related conditions, Greenbrook has delivered over 1.3 million treatments to 40,000+ patients. Our mission is to transform mental health care and improve lives through innovative solutions.
Depression affects more than 16 million Americans. At Greenbrook, we’re changing the way it’s treated—and you can be part of that change.
Learn More

• https://youtu.be/yrr-wlFftT0
• https://www.greenbrooktms.com/patient-stories
• https://www.greenbrookproviders.com
  

GBSP25
About Us
Neuronetics, Inc. is a leading mental health company dedicated to transforming lives through innovative treatments. Now joined with Greenbrook Mental Wellness Centers, we offer FDA-cleared NeuroStar® TMS and Spravato® therapies for major depressive disorder and treatment-resistant depression across 95+ clinics nationwide. Together, we’re expanding access to life-changing care—combining cutting-edge technology with clinical expertise to make a real impact in the mental health space.